This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
Mus musculus
In vitro/In vivo
In vitro
In vivo
By sample type
Blood
Breast cancer cells (4T1)
Breast cancer cells (MDA-MB-231)
Colon cancer cell (SW48)
Drug-resistant acute lymphoblastic leukemia cell (CCRF-CEM MDR variant VLB100)
Embryonic kidney cell (HEK293T)
Epidermal melanocyte (HEMa-LP)
Fetal human colon epithelial cell (FHC)
Mammary gland cells (MCF10A)
Mammary gland cells (NMuMG)
Plasma
By sample status
24 hr culture
72 hr culture
Healthy_timepoint1
Healthy_timepoint2
Normal
Pollen allergy_timepoint1
Pollen allergy_timepoint2
Sample A_Biooscientific
Sample A_Illumina
Sample A_NEB
Sample B_Biooscientific
Sample B_NEB
Sample C_NEB
Transplant islets into mouse xenotransplantation-rejected
Type 1 diabetes
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-328-3p
MIMAT0000752
3.0e-5
5.0e-1
Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits.
Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
1.1e-7
4.8e-1
Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types.
BMC Genomics. 2012 Aug 1;13:357. doi: 10.1186/1471-2164-13-357.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
2.9e-15
3.9e-1
Identifying mRNA, microRNA and protein profiles of melanoma exosomes.
PLoS One. 2012;7(10):e46874. doi: 10.1371/journal.pone.0046874. Epub 2012 Oct 9.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
0.0e+0
3.5e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
0.0e+0
3.6e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
0.0e+0
3.0e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
0.0e+0
3.3e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
0.0e+0
2.8e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
0.0e+0
2.8e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
0.0e+0
4.8e-1
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
0.0e+0
3.5e-1
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
0.0e+0
2.9e-1
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
0.0e+0
3.4e-1
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
0.0e+0
1.2e-1
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
0.0e+0
4.4e-2
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
0.0e+0
4.2e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
0.0e+0
1.5e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
0.0e+0
4.1e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
0.0e+0
2.8e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
0.0e+0
9.4e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
0.0e+0
2.4e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
0.0e+0
3.5e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
1.4e-15
1.4e-15
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000203_2
29
/
0
/
29
hsa-miR-328-3p
MIMAT0000752
4.3e-3
4.7e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000203_2
29
/
0
/
29
[1]